GenixPharmaceucticals Corporation (GENX) - Total Liabilities

Latest as of January 2026: CA$1.51 Million CAD ≈ $1.09 Million USD

Based on the latest financial reports, GenixPharmaceucticals Corporation (GENX) has total liabilities worth CA$1.51 Million CAD (≈ $1.09 Million USD) as of January 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore GenixPharmaceucticals Corporation (GENX) cash flow conversion to assess how effectively this company generates cash.

GenixPharmaceucticals Corporation - Total Liabilities Trend (2015–2025)

This chart illustrates how GenixPharmaceucticals Corporation's total liabilities have evolved over time, based on quarterly financial data. See net assets of GenixPharmaceucticals Corporation for net asset value and shareholders' equity analysis.

GenixPharmaceucticals Corporation Competitors by Total Liabilities

The table below lists competitors of GenixPharmaceucticals Corporation ranked by their total liabilities.

Company	Country	Total Liabilities
Nuwellis Inc NASDAQ:NUWE	USA	$4.07 Million
NeutriSci International Inc V:NU	Canada	CA$1.04 Million
DP Poland Plc LSE:DPP	UK	GBX17.71 Million
Troubadour Resources Inc V:TR	Canada	CA$325.75K
OSX Brasil S.A SA:OSXB3	Brazil	R$10.59 Billion
STRATA Skin Sciences Inc NASDAQ:SSKN	USA	$27.61 Million
Nicolas Miguet et Associes SA PA:MLNMA	France	€1.05 Million
Asian Television Network International Ltd V:SAT	Canada	CA$6.63 Million

Liability Composition Analysis (2015–2025)

This chart breaks down GenixPharmaceucticals Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see GENX market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.02	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	42.75	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how GenixPharmaceucticals Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for GenixPharmaceucticals Corporation (2015–2025)

The table below shows the annual total liabilities of GenixPharmaceucticals Corporation from 2015 to 2025.

Year	Total Liabilities	Change
2025-10-31	CA$1.47 Million ≈ $1.06 Million	+19.66%
2024-10-31	CA$1.23 Million ≈ $888.86K	-9.71%
2023-10-31	CA$1.36 Million ≈ $984.40K	+29.17%
2022-10-31	CA$1.05 Million ≈ $762.10K	+39.50%
2021-10-31	CA$755.19K ≈ $546.29K	+54.16%
2020-10-31	CA$489.88K ≈ $354.37K	+494.44%
2019-10-31	CA$82.41K ≈ $59.61K	-24.50%
2018-10-31	CA$109.15K ≈ $78.96K	-59.99%
2017-10-31	CA$272.80K ≈ $197.34K	+300.95%
2016-10-31	CA$68.04K ≈ $49.22K	-38.58%
2015-10-31	CA$110.78K ≈ $80.13K	--

About GenixPharmaceucticals Corporation

V:GENX Canada Drug Manufacturers - Specialty & Generic

Market Cap

$885.77K

CA$1.22 Million CAD

Market Cap Rank

#30480 Global

#1606 in Canada

Share Price

CA$0.02

Change (1 day)

+0.00%

52-Week Range

CA$0.02 - CA$0.04

All Time High

CA$0.29